Neli Boneva

547 total citations
13 papers, 384 citations indexed

About

Neli Boneva is a scholar working on Psychiatry and Mental health, Neurology and Pharmacology. According to data from OpenAlex, Neli Boneva has authored 13 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Psychiatry and Mental health, 5 papers in Neurology and 4 papers in Pharmacology. Recurrent topics in Neli Boneva's work include Myasthenia Gravis and Thymoma (5 papers), Dementia and Cognitive Impairment Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Neli Boneva is often cited by papers focused on Myasthenia Gravis and Thymoma (5 papers), Dementia and Cognitive Impairment Research (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Neli Boneva collaborates with scholars based in Denmark, United States and United Kingdom. Neli Boneva's co-authors include Talma Brenner, Lars Lau Rakêt, Clive Ballard, Alireza Atri, José Luís Molinuevo, Pierre N. Tariot, Lutz Frölich, Jeffrey L. Cummings, Tama Evron and Hermona Soreq and has published in prestigious journals such as JAMA, Neurology and The Lancet Neurology.

In The Last Decade

Neli Boneva

10 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neli Boneva Denmark 9 137 99 97 96 79 13 384
Christian von Hehn United States 10 65 0.5× 47 0.5× 219 2.3× 62 0.6× 98 1.2× 21 509
Miquel Baquero Spain 9 78 0.6× 42 0.4× 151 1.6× 91 0.9× 65 0.8× 17 362
Wan Chi Lau United States 4 150 1.1× 33 0.3× 255 2.6× 69 0.7× 56 0.7× 6 452
M Maggini Italy 7 99 0.7× 36 0.4× 108 1.1× 159 1.7× 52 0.7× 14 385
Pamela Cyrus United States 7 190 1.4× 30 0.3× 129 1.3× 192 2.0× 42 0.5× 8 386
Aidan Power United States 11 175 1.3× 30 0.3× 282 2.9× 176 1.8× 127 1.6× 25 554
Kasia Lobello United States 8 146 1.1× 15 0.2× 112 1.2× 116 1.2× 50 0.6× 10 434
Daniel D. Christensen United States 13 89 0.6× 28 0.3× 84 0.9× 94 1.0× 36 0.5× 21 315
Randolph D. Andrews United States 10 46 0.3× 79 0.8× 230 2.4× 125 1.3× 99 1.3× 20 479
M. Rainer Austria 13 102 0.7× 29 0.3× 109 1.1× 119 1.2× 49 0.6× 20 374

Countries citing papers authored by Neli Boneva

Since Specialization
Citations

This map shows the geographic impact of Neli Boneva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neli Boneva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neli Boneva more than expected).

Fields of papers citing papers by Neli Boneva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neli Boneva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neli Boneva. The network helps show where Neli Boneva may publish in the future.

Co-authorship network of co-authors of Neli Boneva

This figure shows the co-authorship network connecting the top 25 collaborators of Neli Boneva. A scholar is included among the top collaborators of Neli Boneva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neli Boneva. Neli Boneva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Tassorelli, Cristina, Peter J. Goadsby, Andrew Charles, et al.. (2025). Long-term safety, tolerability, and efficacy of eptinezumab in chronic cluster headache (CHRONICLE): an open-label safety trial. The Lancet Neurology. 24(5). 429–440.
2.
Jensen, Rigmor, Cristina Tassorelli, Stewart J. Tepper, et al.. (2025). Efficacy and Safety of Eptinezumab in Episodic Cluster Headache. JAMA Neurology. 82(7). 706–706. 2 indexed citations
3.
4.
Ballard, Clive, Alireza Atri, Neli Boneva, et al.. (2019). Enrichment factors for clinical trials in mild‐to‐moderate Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 5(1). 164–174. 25 indexed citations
5.
Frölich, Lutz, Alireza Atri, Clive Ballard, et al.. (2019). Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer’s Disease. Journal of Alzheimer s Disease. 67(1). 303–313. 12 indexed citations
6.
Cummings, Jeffrey L., Alireza Atri, Clive Ballard, et al.. (2018). Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer’s disease clinical program. Alzheimer s Research & Therapy. 10(1). 116–116. 15 indexed citations
7.
Atri, Alireza, Lutz Frölich, Clive Ballard, et al.. (2018). Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease. JAMA. 319(2). 130–130. 125 indexed citations
8.
Herrmann, Nathan, Serge Gauthier, Neli Boneva, & Ole Lemming. (2013). A randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease. International Psychogeriatrics. 25(6). 919–927. 43 indexed citations
9.
Boneva, Neli, et al.. (2006). Major pathogenic effects of anti-MuSK antibodies in Myasthenia Gravis. Journal of Neuroimmunology. 177(1-2). 119–131. 32 indexed citations
10.
Boneva, Neli, et al.. (2006). Stimulated-single fiber electromyography monitoring of anti-sense induced changes in experimental autoimmune myasthenia gravis. Neuroscience Research. 55(1). 40–44. 9 indexed citations
11.
Brenner, Talma, et al.. (2003). The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. The FASEB Journal. 17(2). 214–222. 95 indexed citations
12.
Boneva, Neli, Talma Brenner, & Zohar Argov. (2000). Gabapentin may be hazardous in myasthenia gravis. Muscle & Nerve. 23(8). 1204–1208. 25 indexed citations
13.
Boneva, Neli, Talma Brenner, & Zohar Argov. (1999). Gabapentin May Be Hazardous in Myasthenia Gravis. Topics in Pain Management. 14(11). 44–44. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian von Hehn Breakdown of academic impact, for papers by Miquel Baquero Breakdown of academic impact, for papers by Wan Chi Lau Breakdown of academic impact, for papers by M Maggini Breakdown of academic impact, for papers by Pamela Cyrus Breakdown of academic impact, for papers by Aidan Power Breakdown of academic impact, for papers by Kasia Lobello Breakdown of academic impact, for papers by Daniel D. Christensen Breakdown of academic impact, for papers by Randolph D. Andrews Breakdown of academic impact, for papers by M. Rainer
Rankless by CCL
2026